Recursion Pharmaceuticals...

NASDAQ: RXRX · Real-Time Price · USD
5.79
0.15 (2.66%)
At close: Aug 15, 2025, 2:57 PM

Recursion Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4 -6.25 -5.65 -16.38
PEG Ratio
-0.57 -0.39 -0.19 -0.16
PS Ratio
31.50 45.98 34.11 291.68
PB Ratio
1.79 4.42 2.79 5.37
P/FCF Ratio
-4.97 -6.82 -11.2 -14.7
P/OCF Ratio
-5.16 -7.12 -16.2 -18.39
OCF/S Ratio
-6.1 -6.46 -2.1 -15.86
Debt / Equity Ratio
0.10 0.11 0.10 0.02
Quick Ratio
3.81 4.70 5.67 11.43
Current Ratio
3.81 4.70 5.68 11.46
Asset Turnover
0.04 0.07 0.06 0.02
Interest Coverage
-304.71 -3.61K -4.47K -61.92
Return on Equity
-0.45 -0.71 -0.49 -0.33
Return on Assets
-0.32 -0.5 -0.34 -0.29
Return on Invested Capital
-0.37 -0.61 -0.4 -0.31
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.23 0.04 -0.22 0.09
Net Profit Margin
-7.88 -7.36 -6.03 -17.81
Pretax Profit Margin
-7.9 -7.45 -6.04 -18.65
Operating Profit Margin
-8.14 -7.85 -6.19 -18.28
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-7.25 -6.72 -5.74 -17.44